NUWE Nuwellis, Inc.

BEARISH Impact: 8/10 PRESS-RELEASE
Horizon immediate Filed Jun 5, 2026 Processed 7d 20h ago Wire GlobeNewswire
Press release: offering

Price Chart

Loading chart...

Executive Summary

Nuwellis priced a public offering of 20M shares (plus warrants) at $0.30 per unit for ~$6M gross proceeds, alongside a concurrent private placement to reprice existing warrants to $0.30. The offering is severely dilutive relative to the company's $1M market cap and signals acute capital needs, consistent with the company's distressed financial position.

Key Financial Metrics

Deal Value
$6.0M

Actionable Insight

The offering is deeply dilutive and signals severe financial distress. Traders should expect significant downward pressure on the stock as the market prices in the dilution and potential further weakness. Monitor for stockholder vote on warrant exercises and any reverse stock split announcement.

Key Facts

  • Public offering of 20,000,000 shares (or pre-funded warrants) at $0.30 per share with accompanying warrants for ~$6M gross proceeds.
  • Series C Warrants (60M shares) and Series D Warrants (20M shares) exercisable at $0.30, subject to stockholder approval and reverse stock split.
  • Concurrent private placement to reprice existing warrants to $0.30, also subject to stockholder approval.
  • Offering priced at $0.30 per unit; shares trade near similar levels, implying no premium to market.
  • Company market cap is ~$1M, making the $6M offering more than 6x the current equity value.
  • Ladenburg Thalmann acted as exclusive placement agent.

Financial Impact

Gross proceeds of ~$6M from the offering, which is over 6x the company's $1M market cap, indicating massive dilution.

dilutionshare countcash position

Risk Factors

  • Massive dilution from 20M new shares plus up to 80M additional shares from warrants.
  • Potential failure to obtain stockholder approval for warrant exercises could create uncertainty.
  • Reverse stock split may be required for Nasdaq compliance, adding further volatility.
  • Company has a history of poor stock performance (0% win rate on prior reports) and negative alpha.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3307359
14 reports for NUWE
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+5▲ +75.71%May 29, 2026
Filters
Rows
Reports for NUWE — sortable, filterable
Type Now
Jun 10, 2026
2d ago
8-K
BEARISH ★ 7/10
$0.1440 awaiting T+1awaiting T+1$0.1400 (+2.78%)
Jun 10, 2026
2d ago
Press Release
NEUTRAL ★ 4/10
$0.1440 awaiting T+1awaiting T+1$0.1400 (−2.78%)
Jun 9, 2026
4d ago
Press Release
BEARISH ★ 7/10
$0.1458 awaiting T+1awaiting T+1$0.1400 (+3.98%)
Jun 8, 2026
4d ago
424B4
BEARISH ★ 7/10
$0.1350 awaiting T+1awaiting T+1$0.1400 (−3.70%)
Jun 5, 2026
7d ago
Press Release
BEARISH ★ 8/10
$0.3007 awaiting T+1awaiting T+1$0.1400 (+53.44%)
Jun 4, 2026
8d ago
S-1/A
BEARISH ★ 7/10
$0.4300 $0.1700▲ +60.47%▲ +57.87%$0.1400 (+67.44%)
May 29, 2026
14d ago
S-1/A
BEARISH ★ 7/10
$0.7000 $0.5900▲ +15.71%▲ +15.86%$0.1400 (+80.00%)
May 22, 2026
21d ago
S-1
BEARISH ★ 7/10
$0.9100 $0.7600▲ +16.48%▲ +16.50%$0.1400 (+84.62%)
May 12, 2026
4w ago
Press Release
BEARISH ★ 7/10
$1.03 $1.03· 0.00%▲ +0.58%$0.1400 (+86.41%)
May 5, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$1.11 $1.09▼ −1.80%▼ −3.19%$0.1400 (−87.39%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (52h 23m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access